115 related articles for article (PubMed ID: 2878468)
1. Animal models in psychiatric research.
Matthysse S
Prog Brain Res; 1986; 65():259-70. PubMed ID: 2878468
[No Abstract] [Full Text] [Related]
2. Mysteries of the brain. Why is mental illness so hard to treat?
Miller G
Science; 2012 Oct; 338(6103):32-3. PubMed ID: 23042865
[No Abstract] [Full Text] [Related]
3. [Status of and perspectives on psychiatric genomic medicine].
Mors NP; Børglum AD
Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
[No Abstract] [Full Text] [Related]
4. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders.
Zhang ZJ
Life Sci; 2004 Aug; 75(14):1659-99. PubMed ID: 15268969
[TBL] [Abstract][Full Text] [Related]
5. Mental disorders. Targeting the brain.
Hooper J
Time; 1996; 148(14):46-50. PubMed ID: 10161473
[No Abstract] [Full Text] [Related]
6. Scientific models for psychopathology in the 1970's.
Zubin J
Semin Psychiatry; 1972 Aug; 4(3):283-96. PubMed ID: 4680226
[No Abstract] [Full Text] [Related]
7. The study of psychiatric disease genes and drugs in zebrafish.
Haesemeyer M; Schier AF
Curr Opin Neurobiol; 2015 Feb; 30():122-30. PubMed ID: 25523356
[TBL] [Abstract][Full Text] [Related]
8. Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.
Takao K; Yamasaki N; Miyakawa T
Neurosci Res; 2007 Jun; 58(2):124-32. PubMed ID: 17524507
[TBL] [Abstract][Full Text] [Related]
9. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
[No Abstract] [Full Text] [Related]
10. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
11. Ethical problems in pharmacogenetic studies of psychiatric disorders.
Serretti A; Artioli P
Pharmacogenomics J; 2006; 6(5):289-95. PubMed ID: 16550208
[No Abstract] [Full Text] [Related]
12. Lithium: sixty years thereafter.
Rybakowski JK
Neuropsychobiology; 2010; 62(1):5-7. PubMed ID: 20453529
[No Abstract] [Full Text] [Related]
13. Pediatric drug research and mental illness.
Sallee FR
FDA Consum; 2003; 37(1):40. PubMed ID: 12625307
[No Abstract] [Full Text] [Related]
14. The myth of the magic antipsychotic.
Moncrieff J
Ment Health Today; 2008 Jun; ():18-9, 22. PubMed ID: 18663800
[No Abstract] [Full Text] [Related]
15. Psychiatric disorders.
Devinsky O; Miceli MT
Adv Neurol; 2002; 90():277-93. PubMed ID: 12068459
[No Abstract] [Full Text] [Related]
16. Drugs for psychiatric disorders.
Treat Guidel Med Lett; 2006 Jun; 4(46):35-46. PubMed ID: 16770298
[No Abstract] [Full Text] [Related]
17. Pharmacogenetic considerations in the treatment of psychiatric disorders.
Lohoff FW; Ferraro TN
Expert Opin Pharmacother; 2010 Feb; 11(3):423-39. PubMed ID: 20102306
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric illness in mental retardation: an update on pharmacotherapy.
Masi G; Luccherino L
Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
Wood MD; Wren PB
Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
[TBL] [Abstract][Full Text] [Related]
20. [Experience with reactivant in psychiatric patients].
Guensberger E; Adamisová D; Kolibás E
Agressologie; 1980; 21(A):63-5. PubMed ID: 6113774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
